These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11356107)

  • 1. Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis.
    Iwata Y; Arisawa M; Hamada R; Kita Y; Mizutani MY; Tomioka N; Itai A; Miyamoto S
    J Med Chem; 2001 May; 44(11):1718-28. PubMed ID: 11356107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein structure-based de novo design and synthesis of aldose reductase inhibitors.
    Iwata Y; Naito S; Itai A; Miyamoto S
    Drug Des Discov; 2001; 17(4):349-59. PubMed ID: 11765138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G; Ferrari AM; Costantino L; Gamberini MC
    Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and activity of a new series of (Z)-3-phenyl-2-benzoylpropenoic acid derivatives as aldose reductase inhibitors.
    Wang SJ; Yan JF; Hao D; Niu XW; Cheng MS
    Molecules; 2007 Apr; 12(4):885-95. PubMed ID: 17851441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography.
    Oka M; Matsumoto Y; Sugiyama S; Tsuruta N; Matsushima M
    J Med Chem; 2000 Jun; 43(12):2479-83. PubMed ID: 10882376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
    Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives.
    Sun WS; Park YS; Yoo J; Park KD; Kim SH; Kim JH; Park HJ
    J Med Chem; 2003 Dec; 46(26):5619-27. PubMed ID: 14667216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
    Naeem S; Hylands P; Barlow D
    Bioorg Med Chem; 2012 Feb; 20(3):1251-8. PubMed ID: 22261024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
    Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y
    Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design synthesis and evaluation of novel aldose reductase inhibitors: The case of indolyl-sulfonyl-phenols.
    Koutsopoulos K; Lavrentaki V; Antoniou I; Kousaxidis A; Lefkopoulou M; Tsantili-Kakoulidou A; Kovacikova L; Stefek M; Nicolaou I
    Bioorg Med Chem; 2020 Aug; 28(15):115575. PubMed ID: 32631572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
    Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
    J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
    Sever B; Altıntop MD; Demir Y; Yılmaz N; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Chem Biol Interact; 2021 Aug; 345():109576. PubMed ID: 34252406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening for inhibitors of human aldose reductase.
    Kraemer O; Hazemann I; Podjarny AD; Klebe G
    Proteins; 2004 Jun; 55(4):814-23. PubMed ID: 15146480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific interaction of a novel spirosuccinimide type aldose reductase inhibitor, AS-3201, with aldose reductase.
    Kurono M; Fujiwara I; Yoshida K
    Biochemistry; 2001 Jul; 40(28):8216-26. PubMed ID: 11444967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Aldose Reductase Inhibitory Activity of Botryllazine A Derivatives.
    Saito R; Ishibashi K; Noumi M; Uno S; Higashi S; Goto M; Kuwahara S; Komatsu T
    Chem Pharm Bull (Tokyo); 2019; 67(6):556-565. PubMed ID: 31155561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
    Eisenmann M; Steuber H; Zentgraf M; Altenkämper M; Ortmann R; Perruchon J; Klebe G; Schlitzer M
    ChemMedChem; 2009 May; 4(5):809-19. PubMed ID: 19301313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK; Sundaram K; Ravi S
    Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
    Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How reliable are current docking approaches for structure-based drug design? Lessons from aldose reductase.
    Zentgraf M; Steuber H; Koch C; La Motta C; Sartini S; Sotriffer CA; Klebe G
    Angew Chem Int Ed Engl; 2007; 46(19):3575-8. PubMed ID: 17394265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.